Danaher | DHR - Operating Expenses

Stock Price
177.25
Daily Change
-1.32 -0.74%
Monthly
-5.29%
Yearly
-10.09%
Q2 Forecast
173.46

Danaher reported $52.95B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Agilent USD 1.44B 27M Dec/2025
Align Technology USD 822.85M 11.8M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Bio Techne USD 241.42M 2.52M Dec/2025
Bio-Rad Laboratories USD 6.74B 6.16B Sep/2025
Boston Scientific USD 4.04B 18M Dec/2025
Bruker USD 900.9M 124.3M Dec/2025
Charles River Laboratories USD 918.41M 2.49B Dec/2025
Danaher USD 52.95B 47.61B Mar/2026
Dentsply International USD 423M 1.06B Dec/2025
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
ESCO Technologies USD 251.27M 35.88M Dec/2025
Fortive USD 897M 1.39B Dec/2025
Henry Schein USD 3.25B 110M Dec/2025
Illumina USD 903M 69M Dec/2025
Intuitive Surgical USD 1.91B 89.8M Mar/2026
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Keysight Technologies USD 1.26B 38M Dec/2025
Laboratory Of America USD 3.13B 32.4M Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Mettler Toledo International USD 777.8M 42.3M Dec/2025
Myriad Genetics USD 212.8M 16.2M Dec/2025
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quest Diagnostics USD 2.5B 76M Mar/2026
Quidel USD 760.9M 1.28B Dec/2025
Repligen USD 177.94M 1.82M Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
Roper Industries USD 1.53B 55.4M Mar/2026
Stryker USD 5.2B 505M Dec/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Waters USD 661.85M 1.67B Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025